The Foreign Function & Memory API in Java provides significantly easier access to functions in C libraries than the outdated ...
Google has signed agreements with five U.S. electric utilities in states from Arkansas to Minnesota to curtail its electricity use during periods of peak demand, the company said on March 19, in its ...
Meta struck a massive chip deal with Nvidia that includes new standalone CPUs and next-generation GPUs and Vera Rubin rack-scale systems. The social media giant will also use Nvidia for networking ...
A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...
US Immigration and Customs Enforcement is asking companies to provide information about “commercial Big Data and Ad Tech” products that would “directly support investigations activities,” according to ...
Forbes contributors publish independent expert analyses and insights. Randy Bean is a noted Senior Advisor, Author, Speaker, Founder, & CEO. This voice experience is generated by AI. Learn more. This ...
Java ranked third in the Tiobe Index for January 2026 at 8.71%, holding steady behind Python and C and just ahead of C++. Tiobe named C# its Programming Language of the Year for 2025 after the largest ...
Starting this week, ICE can use Medicaid data in deportation cases. A judge rejected a legal challenge against the practice brought by Democrat-led states last year. Starting Tuesday, the Trump ...
The Transportation Security Administration is flagging passengers for Immigration and Customs Enforcement to identify and detain travelers subject to deportation orders. The Transportation Security ...
The last time I wrote an article on Structure Therapeutics Inc. (GPCR) it was in a Seeking Alpha article entitled "Structure Therapeutics: Potential To Have Best-In-class GLP-1 Agonist For Obesity ...
Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results